Ectopic expression of JAK2 in IGROV1 CR cells with depleted SENP1 restored cisplatin resistance of IGROV1 CR cells to the similar levels as cells treated with control siGL2, suggesting that JAK2 is the primary target of SENP1 to promote platinum-resistance in ovarian cancer cells. Here, JAK2 is linked to ovarian cancer.